Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial

di Johnston, Christine, Brown, Elizabeth R., Stewart, Jenell, Karita, Helen C.Stankiewicz, Kissinger, Patricia J., Dwyer, John, Hosek, Sybil, Oyedele, Temitope, Paasche-Orlow, Michael K., Paolino, Kristopher, Heller, Kate B., Leingang, Hannah, Haugen, Harald S., Dong, Tracy Q., Bershteyn, Anna, Sridhar, Arun R., Poole, Jeanne, Noseworthy, Peter A., Ackerman, Michael J., Morrison, Susan, Greninger, Alexander L., Huang, Meei-Li, Jerome, Keith R., Wener, Mark H., Wald, Anna, Schiffer, Joshua T., Celum, Connie, Chu, Helen Y., Barnabas, Ruanne V., Baeten, Jared M.
Pubblicato in EClinicalMedicine (2021)